Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater increase » year increase (Expand Search)
alter decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater increase » year increase (Expand Search)
alter decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
-
2621
-
2622
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2623
-
2624
-
2625
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2626
-
2627
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2628
-
2629
-
2630
-
2631
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2632
-
2633
-
2634
-
2635
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2636
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2637
-
2638
-
2639
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2640